| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,063 |
6,452 |
$660K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,546 |
1,434 |
$195K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,974 |
4,480 |
$190K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
882 |
798 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
508 |
490 |
$42K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
315 |
308 |
$18K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
130 |
82 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
82 |
78 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
295 |
214 |
$4K |
| 90686 |
|
184 |
172 |
$3K |
| 0072A |
|
88 |
79 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
85 |
75 |
$3K |
| 99215 |
Prolong outpt/office vis |
17 |
16 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
116 |
61 |
$1K |
| 92552 |
|
65 |
39 |
$1K |
| 0071A |
|
32 |
28 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
89 |
84 |
$960.64 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35 |
29 |
$811.16 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
33 |
33 |
$664.29 |
| 90461 |
|
140 |
87 |
$660.01 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
55 |
51 |
$600.08 |
| 99201 |
|
15 |
15 |
$560.41 |
| 87634 |
|
15 |
14 |
$540.54 |
| 87400 |
|
56 |
33 |
$428.15 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
103 |
97 |
$415.21 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$321.49 |
| 36416 |
|
13 |
12 |
$101.09 |
| 99173 |
|
31 |
13 |
$32.10 |
| 96160 |
|
14 |
13 |
$24.19 |
| 99000 |
|
14 |
14 |
$3.89 |
| 91307 |
|
216 |
199 |
$0.00 |